Shanghai Huide Science & Technology Co.,Ltd (SHA:603192)
China · Delayed Price · Currency is CNY 22.85
+0.13 (0.57%)
May 6, 2026, 3:00 PM CST
SHA:603192 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,489 | 2,472 | 2,553 | 2,524 | 2,835 | 3,043 |
Other Revenue | - | - | 117.95 | 188.38 | 181.95 | 148.28 |
| 2,489 | 2,472 | 2,671 | 2,712 | 3,017 | 3,191 | |
Revenue Growth (YoY) | -4.67% | -7.43% | -1.51% | -10.12% | -5.46% | 113.08% |
Cost of Revenue | 2,126 | 2,115 | 2,324 | 2,437 | 2,735 | 2,852 |
Gross Profit | 362.76 | 357.64 | 347.33 | 274.64 | 282.53 | 339.54 |
Selling, General & Admin | 158.46 | 154.28 | 145.09 | 132.16 | 112.54 | 95.39 |
Research & Development | 84.5 | 79.78 | 71.35 | 80.6 | 97.79 | 113.13 |
Other Operating Expenses | 7.64 | 4.51 | -6.36 | -3.85 | 7.98 | 7.19 |
Operating Expenses | 250.6 | 238.57 | 214.13 | 218.72 | 235.86 | 224.9 |
Operating Income | 112.15 | 119.07 | 133.2 | 55.92 | 46.67 | 114.64 |
Interest Expense | - | - | -2.21 | -5.06 | -6.31 | -2.43 |
Interest & Investment Income | - | - | 5.08 | 6.11 | 7.32 | 6.78 |
Currency Exchange Gain (Loss) | - | - | 0.14 | 0.74 | 4.04 | -0.51 |
Other Non Operating Income (Expenses) | -15.97 | -15.94 | -1.21 | -1.18 | -1.6 | -1.35 |
EBT Excluding Unusual Items | 96.1 | 103.13 | 135 | 56.54 | 50.12 | 117.13 |
Gain (Loss) on Sale of Investments | -0.02 | -0.02 | -0.04 | -0.05 | 0.01 | - |
Gain (Loss) on Sale of Assets | 0.02 | 0 | 0.03 | 0.07 | 0.1 | 0.01 |
Asset Writedown | -13.23 | -17.17 | -2.38 | -1.32 | - | - |
Other Unusual Items | - | - | 4.97 | 2.83 | 5.28 | 5.69 |
Pretax Income | 82.87 | 85.95 | 137.57 | 58.07 | 55.51 | 122.84 |
Income Tax Expense | 5.77 | 4.66 | 13.02 | -5.81 | -6.4 | 5.01 |
Earnings From Continuing Operations | 77.1 | 81.29 | 124.56 | 63.88 | 61.92 | 117.83 |
Net Income | 77.1 | 81.29 | 124.56 | 63.88 | 61.92 | 117.83 |
Net Income to Common | 77.1 | 81.29 | 124.56 | 63.88 | 61.92 | 117.83 |
Net Income Growth | -40.31% | -34.74% | 95.00% | 3.16% | -47.45% | -5.15% |
Shares Outstanding (Basic) | 143 | 140 | 138 | 139 | 123 | 139 |
Shares Outstanding (Diluted) | 143 | 140 | 138 | 139 | 123 | 139 |
Shares Change (YoY) | 2.90% | 1.27% | -0.33% | 13.20% | -11.90% | 0.02% |
EPS (Basic) | 0.54 | 0.58 | 0.90 | 0.46 | 0.50 | 0.85 |
EPS (Diluted) | 0.54 | 0.58 | 0.90 | 0.46 | 0.50 | 0.85 |
EPS Growth | -41.99% | -35.56% | 95.65% | -8.00% | -40.91% | -5.17% |
Free Cash Flow | 256.99 | 203.75 | -21.6 | 192.79 | -40.57 | 128.97 |
Free Cash Flow Per Share | 1.79 | 1.45 | -0.16 | 1.39 | -0.33 | 0.93 |
Dividend Per Share | - | - | 0.375 | 0.180 | 0.150 | 0.258 |
Dividend Growth | - | - | 108.33% | 20.00% | -41.79% | -6.93% |
Gross Margin | 14.57% | 14.46% | 13.00% | 10.13% | 9.36% | 10.64% |
Operating Margin | 4.51% | 4.82% | 4.99% | 2.06% | 1.55% | 3.59% |
Profit Margin | 3.10% | 3.29% | 4.66% | 2.35% | 2.05% | 3.69% |
Free Cash Flow Margin | 10.32% | 8.24% | -0.81% | 7.11% | -1.34% | 4.04% |
EBITDA | 181.38 | 187.68 | 199.36 | 125.72 | 111.01 | 177.65 |
EBITDA Margin | 7.29% | 7.59% | 7.46% | 4.64% | 3.68% | 5.57% |
D&A For EBITDA | 69.23 | 68.61 | 66.15 | 69.8 | 64.34 | 63.01 |
EBIT | 112.15 | 119.07 | 133.2 | 55.92 | 46.67 | 114.64 |
EBIT Margin | 4.51% | 4.82% | 4.99% | 2.06% | 1.55% | 3.59% |
Effective Tax Rate | 6.96% | 5.43% | 9.46% | - | - | 4.08% |
Revenue as Reported | - | - | 2,671 | 2,712 | 3,017 | 3,191 |
Advertising Expenses | - | - | 1.36 | 1.74 | 0.19 | 0.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.